The Japan radiotherapy market was valued at USD 444.4 million in 2024, and IMARC Group projects it to reach USD 719.5 million by 2033, growing at a CAGR of 5.28% from 2025 to 2033. Market expansion is primarily driven by rising healthcare expenditure and the increasing demand for effective treatment options that alleviate symptoms of advanced cancers. https://www.imarcgroup.com/japan-radiotherapy-market